Abstract: The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.

Abstract: The present invention relates to methods of treatment of acute myeloid leukemia with anti-CD38 antibodies.

Abstract: Antibodies and antigen-binding fragments thereof that bind to human PAC1 are provided. Nucleic acids encoding the antibodies and antigen-binding fragments thereof, vectors, and cells encoding the same are also provided. The antibodies and antigen-binding fragments thereof can inhibit binding of PAC1 to PACAP, and are useful in a number of PAC1 related disorders, including the treatment and/or prevention of headache disorders, including migraine and cluster headache.

Abstract: The present invention is directed to bispecific, heterodimeric immunomodulatory antibodies.

Abstract: The present disclosure provides, in part, compositions comprising peptides that immunospecifically bind to a defined binding partner, such as MHC class I polypeptide-related sequence A (MICA), or an epitope thereon. In some embodiments, the peptides comprise one or more complementarity determining regions relating to the complementarity regions shown in Table 1. The disclosure also provides methods of treating cancer in a subject using the compositions disclosed herein, and methods of isolating human antibodies from cancer patients following immunotherapy.

Abstract: The present invention relates to novel agonistic anti-TrkB antibodies and therapeutic and diagnostic methods and compositions for using the same.

Abstract: The present invention relates to antibodies, e.g., full length antibodies or antigen binding fragments thereof, that specifically bind to BCMA (B-Cell Maturation Antigen) and/or CD3 (Cluster of Differentiation 3). The invention also relates to antibody conjugates (e.g., antibody-drug-conjugates) comprising the BCMA antibodies, compositions comprising the BCMA antibodies, and methods of using the BCMA antibodies and their conjugates for treating conditions associated with cells expressing BCMA (e.g., cancer or autoimmune disease). The invention further relates to heteromultimeric antibodies that specifically bind to CD3 and a tumor cell antigen, (e.g., bispecific antibodies that specifically bind to CD3 and BCMA). Compositions comprising such heteromultimeric antibodies, methods for producing and purifying such heterodimeric antibodies, and their use in diagnostics and therapeutics are also provided.

Abstract: Provided herein are, inter alia, anti-CD73 antibodies and methods of using the same. The antibodies provided include amino acid substitution embodiments affecting the antibody glycosylation state. The antibodies provided herein are, inter alia, useful for the treatment of cancer and effective for inhibition of CD73 activity.

Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.

Abstract: The present disclosure relates to compositions and methods for compositions, methods, and kits for treating cancer using chimeric antigen receptor (CAR) modified cells. Some embodiments of the present disclosure relate to an isolated nucleic acid sequence encoding CAR. The CAR may include an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain. The antigen binding domain may bind to an antigen of a non-essential organ.

Abstract: Provided herein, in one aspect, are antibodies that immunospecifically bind to a human KIT antigen comprising the fourth and/or fifth extracellular Ig-like domains (that is, D4 and/or D5 domains), polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. The antibodies can inhibit KIT activity, such as ligand-induced receptor phosphorylation. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to a KIT antigen, as well as methods of treating or managing a KIT-mediated disorder or disease and methods of diagnosing a KIT-mediated disorder or disease using the antibodies described herein.

Abstract: Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.

Abstract: The present invention provides fully human anti-mesothelin antibodies and immune effector cells targeting mesothelin.

Abstract: The disclosure relates to binding members, especially antibody molecules, which bind to human Maf. The binding members are useful for the determination of the expression level of Maf.

Abstract: The present invention provides a PCSK9 antibody, an antigen-binding fragment thereof, and a medicinal application thereof. Provided in the invention is a chimeric antibody and a humanized antibody, both comprising a CDR of the PCSK9 antibody, and a pharmaceutical composition comprising the PCSK9 antibody and an antigen-binding fragment thereof, and an application of the PCSK9 antibody as a lipid-lowering agent. The invention specifically relates to an application of a humanized PCSK9 antibody for preparing a pharmaceutical drug to treat a PCSK9-induced disease or symptom.

Abstract: Disclosed is an antibody which binds to risperidone, which can be used to detect risperidone in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of risperidone, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.

Abstract: Admixtures comprising an adhesive resin and cellulose are disclosed, in which at least a portion of the cellulose is type-II cellulose. Also disclosed are compositions comprising adhesive resins, in which the adhesive resins comprise a condensation product of formaldehyde and at least one phenolic compound, and the condensation product is formed in the presence of cellulose, wherein at least a portion of the cellulose is type-II cellulose. Articles of manufacture containing the admixtures and compositions, such as plywood and oriented strand board, are also disclosed. In addition, methods of preparing the compositions and articles of manufacture are disclosed.

Abstract: Cellulose nanocrystals (CNCs) from the plant Miscanthus Giganteus (MxG) and a matrix material are present in a composite composition. Impressive yields of MxG-CNCs are obtained through a combination of processing steps including base hydrolysis, bleaching and acid hydrolysis. MxG-CNCs are produced having high aspect ratios, are biorenewable and can be used for a wide range of applications such as nanofillers in composites.

Abstract: The presently disclosed subject matter concerns a microbial biopolymer comprising fucose in its composition. This biopolymer consists of a polysaccharide comprising fucose, which represents at least 10% of its composition. This fucose-containing polysaccharide also contains non-sugar components, namely, acyl group substituents. This disclosed subject matter also concerns the process for the production of the biopolymer, which is obtained cultivation of the bacterium Enterobacter A47 (DSM 23139), using glycerol or glycerol-rich mixtures as carbon sources. The fucose-containing biopolymer of the presently disclosed subject matter may be used in several industrial applications (e.g. pharmaceutical, cosmetics and agro-food industries) and in the treatment of industrial wastes (e.g. oil and metal recovery).

Abstract: A method of forming a microphase separated block copolymer includes exposing a block copolymer to acid vapor under conditions effective to provide the microphase separated block copolymer. The block copolymer includes a first hydrophobic block and a second hydrophobic block that is acid-sensitive. The microphase separated block copolymer includes the first hydrophobic block and a hydrophilic block derived from the second hydrophobic block. Exposing the block copolymer to the acid vapor is conducted in the solid state.

Abstract: Low molecular weight polytetrafluoroethylene powder having a complex viscosity of 1×102 to 7×105 Pa·s at 380° C., containing 5 or less carboxyl groups at ends of the molecule chain per 106 carbon atoms in the main chain, and being substantially free from C8-C14 perfluorocarboxylic acids and salts thereof. Also disclosed is a method for producing low molecular weight polytetrafluoroethylene.

Abstract: The present invention relates to polyethylene resin having excellent impact strength, and more specifically, to polyethylene resin exhibiting excellent impact strength and flexural strength, when prepared into a molded product.

Abstract: A method for producing a high-activity solid PMAO composition is provided, involving: (a) heating an aromatic hydrocarbon solution of TMAL and PMAO containing units having formula (I), and precipitating a solid PMAO composition containing PMAO and TMAL; (b) adding an aromatic hydrocarbon solution of TMAL and PMAO containing units represented by formula (I) to a solution containing the solid PMAO composition; and (c) heating the resulting solution, thereby precipitating a solid PMAO composition. In steps (b) and (c), at least 70% of the PMAO and TMAL in terms of aluminum precipitates. The median diameter d2 of the solid PMAO composition produced in (c) is greater than the median diameter d1 of the solid PMAO composition produced in (a). -[(Me)AlO]n—??(I) In formula (I), n represents an integer of 10-50. An olefin polymerization catalyst using the solid PMAO composition and a method for producing an olefin polymer using this catalyst are also described.

Abstract: A process for preparing conjugated diene (co)polymers comprising polymerizing at least one conjugated diene in the presence of a catalytic system comprising: (a) at least one pyridyl iron (III) complex having general formula (I) or (II): wherein: —R1, R2, R3 and R4, identical or different, represent a hydrogen atom; or are selected from linear or branched, optionally halogenated C1-C20, preferably C1-C15, alkyl groups, optionally substituted cycloalkyl groups, optionally substituted aryl groups; —R5 represents a hydrogen atom, or is selected from linear or branched, optionally halogenated C1-C20, preferably C1-C15, alkyl groups, optionally substituted cycloalkyl groups, optionally substituted aryl groups; —X, identical or different, represent a halogen atom such as, for example, chlorine, bromine, iodine; or are selected from linear or branched C1-C20, preferably C1-C15, alkyl groups, —OCOR6 groups or —OR6 groups wherein R6 is selected from linear or branched C1-C20, preferably C1-C15, alkyl groups.

Abstract: Methods of preparing a polymerization catalyst component is provided, in which a magnesium component, a Lewis acid solubilizing component, a titanium compound, optionally a transition metal compound different than the titanium compound, and typically an inert filler are combined in a slurrying agent and spray-dried to produce a catalyst precursor in the form of a substantially spherical and porous solid particle. The methods and catalysts of this disclosure can provide ethylene homopolymer and copolymer resins having a high molecular weight tail and a broadened molecular weight distribution as compared to more traditional Ziegler-Natta catalysts.

Abstract: The present disclosure provides a polyolefin composition made from or containing: A) from about 60 to about 89% by weight based upon the total weight of the polyolefin composition of a copolymer of butene-1 with ethylene having a copolymerized ethylene content of up to about 18% by mole based upon the molar composition of the copolymer, and no melting peak detectable at the DSC at the second heating scan; and B) from about 11 to about 40% by weight based upon the total weight of the polyolefin composition of an ethylene polymer having density of from about 0.900 to about 0.970 g/cm3, measured according to ISO 1183 at 23° C.; wherein the amounts of A) and B) are referred to the total weight of A)+B) and the DSC second heating scan is carried out with a heating rate of 10° C. per minute. The composition is useful for preparing gaskets.

Abstract: The invention relates to a specific copolymer obtainable by co-polymerizing at least the following monomers: —at least one bicyclic (meth)acrylate ester —at least one C8-C24-alkyl (meth)acrylate —optionally, and preferably, at least one aromatic vinyl monomer; and —optionally other ethylenically unsaturated monomers, whereby the copolymer has a weight averaged molecular weight from 400,000 to 50,000,000 Dalton, as well as to the way to synthesize them and the use of such polymers to modify the rheology of a liquid in which they are soluble.

Abstract: Provided is an antifouling acrylic resin that contains: a first structural unit derived from a first acrylic monomer; a second structural unit derived from a second acrylic monomer into which a polysiloxane side chain is introduced; and a third structural unit derived from a third acrylic monomer into which a photocurable functional group is introduced.

Abstract: An object of the present invention is to provide a multicomponent copolymer for use for producing a rubber composition and a rubber product such as tires and the like excellent in crack resistance and further having low heat generation while maintaining high weather resistance. Further, the present invention is to provide a rubber composition containing the multicomponent copolymer, a crosslinked rubber composition obtained by crosslinking the rubber composition, and a rubber product and a tire using the rubber composition or the crosslinked rubber composition. The multicomponent copolymer of the present invention contains a conjugated diene unit, a non-conjugated olefin unit and an aromatic vinyl unit, wherein the main chain is formed of an acyclic structure alone and the content of the aromatic vinyl unit is 5 mol % or less of the whole multicomponent copolymer.

Abstract: The present invention provides a water-soluble silicone macromer. The water-soluble silicone macromer has a general formula: E-(M1)x-(M2)y, wherein M1 is a repeating unit which is derived from a silicone containing monomer, M2 is a repeating unit which is derived from a first hydrophilic monomer, and E is an ethylenically unsaturated group. The amount of M1 is in a range of 30-60 wt % based on the total weight of the water-soluble silicone macromer, and the amount of M2 is in a range of 40-70 wt % based on the total weight of the water-soluble silicone macromer. A silicone hydrogel composition containing the water-soluble silicone macromer and a silicone hydrogel lens made of the silicone hydrogel composition are also provided herein.

Abstract: Provided is a macromonomer copolymer (Y) including a monomer unit of a specific macromonomer (A) and a monomer unit of a comonomer (B) copolymerizable with the macromonomer (A), in which a value of Hx represented by a specific expression is 0.05 to 0.40.

Abstract: A star block copolymer and a thermoplastic elastomer including plurality of the star block copolymers and a method of making both is taught. The star block copolymers of the present invention include a core component having either a styrene oligomer or ?-methyl styrene oligomer, wherein arms emanate from the core component and the arms are poly(isobutylene-block-styrene) diblock copolymers.

Abstract: The present invention provides for the use of nitrogen compounds of formula (I) and/or of corresponding quaternized and/or protonated compounds for production of polyurethanes, compositions containing these compounds and polyurethane systems, especially polyurethane foams, which have been obtained using the compounds.

Abstract: The present invention relates to an isocyanate reactive component comprising a specific polyol mixture useful for the preparation of homogenous reactive polyurethane compositions. The invention further relates to a reactive polyurethane composition comprising such isocyanate reactive component and an isocyanate component. It also relates to a homogeneous polyurethane foam having good mold release property and surface quality prepared from such reactive polyurethane compositions. In a further aspect, it relates to a polyurethane composite comprising such homogenous polyurethane foam and having good and flat surface appearance after processing.

Abstract: A process for preparing trimers and/or oligomers of diisocyanates is disclosed along with a composition of trimers and/or oligomers formed from diisocyanates and monomeric diisocyanates obtainable by reaction of I. 5-94.999% by weight of A) at least one diisocyanate having a boiling point of less than 250° C. (at standard pressure) and/or B) at least one diisocyanate having a boiling point of 250-350° C. (at standard pressure), in the presence of II. 94.999-5% by weight of C) at least one diisocyanate having a boiling point above 350° C. (at standard pressure), III. in the presence of at least one trimerization catalyst in amounts of 0.001% to 5% by weight, and the amounts of I.-III. add up to 100% by weight.

Abstract: A formulation system contains: (a) a pre-polymer reaction product of a polymeric isocyanate and a polyether polyol, where: (i) the polymeric isocyanate contains five weight-percent or more methylene diphenyl diisocyanate; (ii) the polymeric isocyanate has a functionality of 3.0 or less; (iii) the polyether polyol is present in the pre-polymer at a concentration of one to 25 weight-percent; (iv) the polyol has an equivalent weight of 50 to 500 grams per equivalent; (v) the ?NCO concentration of the pre-polymer is 15 to 31 weight-percent; (vi) the pre-polymer is free of isocyanate trimers; (b) a polyester polyol component containing 10 to 25 weight-percent of free glycol; and (c) a blowing agent that contains less than five weight-percent water; where the ratio of pre-polymer and polyester result in foam having a trimer content of 12 to 22 weight-percent, and an ?NCO index of more than 300 and less than 700.

Abstract: A polyisocyanate composition includes an isocyanurate derivative of xylylene diisocyanate, and a biuret derivative of aliphatic polyisocyanate.

Abstract: A curable composition, a method of making the curable composition, and an article and product produced therefrom are provided. A morpholinedione is contacted with an isocyanate to form a resin composition. The resin composition is reacted with an amine to form the curable composition.

Abstract: Polymers comprising at least one unit of formula 1 and compounds of the formula 1? wherein, in formulae 1 and 1? n is 0, 1, 2, 3 or 4 m is 0, 1, 2, 3 or 4 X is at each occurrence selected from the group consisting of O, S, Se or Te, Q is at each occurrence selected from the group consisting of C, Si or Ge R is at each occurrence selected from the group consisting of hydrogen, C1-30-alkyl, C2-30-alkenyl, C2-30-alkynyl, C5-12-cycloalkyl, C6-18-aryl, R2, R2?, R* are at each occurrence independently selected from the group consisting of hydrogen, C1-30-alkyl, C2-30-alkenyl, C2-30-alkynyl, C5-12-cycloalkyl, C6-18-aryl, 5 to 20 membered hetero-aryl, OR21, OC(O)—R21, C(O)—OR21, C(O)—R21, NR21R22, NR21—C(O)R22, C(O)—NR21R22, N[C(O)R21][C(O)R22], SR21, halogen, CN, SiRSisRSitRSiu and OH, L1 and L2 are independently from each other and at each occurrence selected from the group consisting of C6-30-arylene, 5 to 30 membered heteroarylene.

Abstract: A method for the manufacture of polyether ketone ketone (PEKK), including: (i) providing a 1,4-bis(4-phenoxybenzoyl)benzene-Lewis acid complex; (ii) purifying said 1,4-bis(4-phenoxybenzoyl)benzene-Lewis acid complex; (iii) reacting said 1,4-bis(4-phenoxybenzoyl)benzene-Lewis acid complex with at least one difunctional aromatic acyl chloride in a reaction solvent and optional additional Lewis acid to obtain a product mixture including a PEKK-Lewis acid complex; and (iv) decomplexing the PEKK-Lewis acid complex to obtain a PEKK polymer. Further, a composition including at least 40 wt. % of 1,4-bis(4-phenoxybenzoyl)benzene-Lewis acid complex and an anhydrous aprotic solvent or solvent mixture, characterized in that it includes less than 1 wt. %, preferably less than 0.5 wt. % and in particular less than 0.1 wt. % of molecules including xanthydrol groups and its use for the manufacture of polyether ketone ketone.

Abstract: A method for preparing tyrosine derived polyarylates includes combining a desaminotyrosyl-tyrosine ethyl ester, a desaminotyrosyl-tyrosine benzylester, succinic acid and a catalyst in a flask to produce a first mixture. Methylene chloride is added to the first mixture to produce a first suspension. Diisopropylcarbodiimide (DIPC) is added to the first mixture to produce a first solution. The first solution is added to a non-solvent to produce a precipitate. The precipitate is dissolved in methylene chloride to form a polymer solution. The polymer solution is blended with a slurry to produce polymer shreds. The polymer shreds are blended with a second slurry to produce a tyrosine derived polyarylate.

Abstract: Provided is an aliphatic polycarbonate macropolyol including —OAO— and Z(O—)a as repeating units. In the aliphatic polycarbonate macropolyol, the repeating units —OAO— and Z(O—)a are linked to each other via carbonyl (—C(O)—) linkers or are bonded to hydrogen to form terminal —OH groups. The number of moles of the terminal —OH groups is from aZ to aZ+0.2Z (where Z represents the number of moles of the repeating unit Z(O—)a). Further provided is an aliphatic polycarbonate-co-aromatic polyester macropolyol including —OAO— and Z(O—)a as repeating units. In the aliphatic polycarbonate-co-aromatic polyester macropolyol, the repeating units —OAO— and Z(O—)a are linked via carbonyl (—C(O)—) and —C(O)YC(O)— as linkers or are bonded to hydrogen to form terminal —OH groups.

Abstract: Methods are provided for producing bio-oil polyols, alkoxylating bio-oil polyols to provide polyols, and for employing the alkoxylated bio-oil polyols for making polymers or copolymers of polyesters or polyurethanes.

Abstract: The present invention relates to a polymer comprising a repeating group having the structure of formula (I) wherein R, R1, R2, R3, R4, X, and s are as described herein and salt thereof. Also disclosed is a process of synthesizing such polymers.

Abstract: The present disclosure provides a preparation method of the electroconductive polyimide and a display panel. The preparation method may include: providing aminated carbon nanotubes; and mixing the aminated carbon nanotubes with diamine and dianhydride in a predetermined reaction condition to form a mixture, such that the aminated carbon nanotubes react with the diamine and the dianhydride to generate the electroconductive polyimide. According to the above method, the electroconductive polyimide can be prepared through the reaction between the aminated carbon nanotubes, the diamine, and the dianhydride.

Abstract: A method of making a polyetherimide comprises: combining a bisphenol A dianhydride, p-phenylene diamine and a halogenated aromatic solvent to form a reactant solution; heating the reactant solution to a temperature of 205° C. to 330° C. at a pressure sufficient to prevent boiling to afford a reaction solution; removing water from the reaction solution; maintaining the reaction solution at a temperature of 205° C. to 330° C. and a pressure sufficient to prevent boiling for 10 minutes to 5 hours to form a product mixture comprising the polyetherimide and solvent; and isolating the polyetherimide.

Abstract: A polyimide polymer that includes the reaction product of: (a) at least one diamine selected from the group consisting of a diamine of Structure (I) (b) at least one tetracarboxylic acid dianhydride, and optionally (c) at least one compound containing a first functional group reactive with an amine or an anhydride and at least one second functional group selected from the group consisting of an unsubstituted alkenyl group and an unsubstituted alkynyl group. Each variable in the above formula is defined in the specification.

Abstract: A resin composition capable of forming a cured film having a high refractive index, high transparency and high heat resistance, and a polymer which is used for the resin composition. A polymer having a structural unit of Formula (1): wherein A1 and A2 are each independently an —O— group or a —C(?O)O— group; X is a divalent organic group having at least one aromatic ring or heterocyclic ring, wherein, when the X has two or more aromatic rings or heterocyclic rings, the rings are optionally bonded to each other via a single bond, are optionally bonded to each other via a heteroatom, or optionally form a condensed ring; and Y is a divalent organic group having at least one aromatic ring or condensed ring. A resin composition, includes: the polymer; a cross-linking agent; and a solvent.

Abstract: This invention relates to a composite material comprising a core comprising an organosilica such as a polyhedral oligomeric silsesquioxane (POSS) and a functionalized elastomeric polymer such as poly(n-butyl acrylate) bonded onto said core. The elastomer is preferably functionalised with an amine moiety. The present invention also relates to a polymer comprising a resin such as Bisphenol A diglycidylether (DGEBA) and the aforementioned composite material, and a method for making the composite material. The composite material can improve both the material strength and material toughness of the polymer into which it is mixed.

Abstract: The present invention is a radically curable organosiloxane graft polyvinyl alcohol polymer having structural units represented by both of the following general formula (1) and general formula (2). The present invention provides a radically curable organosiloxane graft polyvinyl alcohol polymer having general properties such as film-forming property and transparency, excellent handleability as a liquid material since solubility in an organic solvent is high, and both of solvent resistance and moldability of the obtained film.